The approval of perpetual futures contracts in the US may expose traders to unforeseen tax and regulatory risks if these products are ultimately deemed to be swaps rather than futures, CME Group Chairman and CEO Terry Duffy has warned. In an interview, Duffy highlighted the ambiguity surrounding the tax implications for US participants due to the lack of clarity on the classification of perpetual futures. The comments come as CME continues its legal challenge against the Commodity Futures Trading Commission (CFTC) over the regulator's approval of perpetual futures contracts. The core issue revolves around whether perpetual futures should be legally categorized as futures or swaps, with Duffy arguing that they should be considered swaps due to the periodic funding payments exchanged between long and short positions.
This classification is crucial as it affects the tax treatment, with futures typically receiving a blended tax treatment under Section 1256 of the US tax code, while swaps are taxed under 'ordinary' taxation. However, the IRS has not provided specific guidance on the tax treatment of perpetual futures, leaving market participants uncertain about how to report these positions.
Legal experts view the issue as complex, with the definition of swaps being broad and encompassing a wide range of financial instruments. The outcome of the court decision could significantly influence the US approach to perpetual futures, and the process is expected to be lengthy, with potential litigation and the need for separate guidance from the IRS.